Oklahoma § 63-1-757.5 Promulgation of rules – Requirements for manufacturers

Oklahoma Statutes

§ 63-1-757.5 — Promulgation of rules – Requirements for manufacturers

Oklahoma § 63-1-757.5

Title 63Public Health And Safety

This text of Oklahoma § 63-1-757.5 (Promulgation of rules – Requirements for manufacturers) is published on Counsel Stack Legal Research, covering Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Okla. Stat. tit. 63, § 63-1-757.5 (2026).

Text

and distributors – Requirements for physicians.

A.The State Board of Pharmacy shall promulgate rules to create a certification program to oversee and regulate the manufacture and distribution of abortion-inducing drugs by manufacturers and distributors licensed by the State Board of Pharmacy.

B.The State Board of Pharmacy shall establish the following requirements for manufacturers and distributors of abortion-inducing drugs, at a minimum: 1. Require completion of the certification process for manufacturers and distributors as described in Section 6 of this act; 2. Require that abortion-inducing drugs be transported and provided in this state only by manufacturers or distributors certified to do so under this program; 3. Notify manufacturers and distributors of physicians certified under

Free access — add to your briefcase to read the full text and ask questions with AI

and distributors – Requirements for physicians. A. The State Board of Pharmacy shall promulgate rules to create a certification program to oversee and regulate the manufacture and distribution of abortion-inducing drugs by manufacturers and distributors licensed by the State Board of Pharmacy. B. The State Board of Pharmacy shall establish the following requirements for manufacturers and distributors of abortion-inducing drugs, at a minimum: 1. Require completion of the certification process for manufacturers and distributors as described in Section 6 of this act; 2. Require that abortion-inducing drugs be transported and provided in this state only by manufacturers or distributors certified to do so under this program; 3. Notify manufacturers and distributors of physicians certified under the Oklahoma Abortion-Inducing Drug Certification Program; 4. Prohibit shipment of abortion-inducing drugs to physicians who become de-certified from the Oklahoma Abortion-Inducing Drug Certification Program; 5. Audit newly certified manufacturers and distributors within ninety (90) calendar days after the manufacturer or distributor is authorized, and annually thereafter, to ensure that all processes and procedures are in place and functioning to support the requirements of the Oklahoma Abortion-Inducing Drug Certification Program; 6. If a manufacturer or distributor is found to be noncompliant, immediately suspend manufacturer's or distributor's certification until the manufacturer or distributor demonstrates full compliance; and 7. Enforce compliance according to Section 12 of this act. C. The State Board of Medical Licensure and Supervision and the State Board of Osteopathic Examiners shall promulgate rules to create a certification program to oversee and regulate the provision of abortion-inducing drugs by physicians licensed by the respective state licensing board. The drugs shall only be provided to patients by fully licensed physicians certified to do so under this program by their respective state licensing boards. D. The State Board of Medical Licensure and Supervision and the State Board of Osteopathic Examiners shall establish the following requirements for physicians providing abortion-inducing drugs, at a minimum: 1. Require completion of the certification process for physicians as described in Section 7 of this act; 2. Audit newly certified physicians within ninety (90) calendar days after the physician is authorized, and annually thereafter, to ensure that all required processes and procedures are in place and functioning to support the requirements of the Oklahoma Abortion- Inducing Drug Certification Program; 3. If a physician is found to be noncompliant, immediately suspend the physician's certification until such time that the physician demonstrates full compliance; 4. Develop a reporting system as specified in Section 9 of this act; and 5. Enforce compliance according to Section 12 of this act.